InflaRx N.V. Common Stock IFRX
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-13T04:11:35.863Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:00:00.60793296Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T04:11:35.420636+00:00
InflaRx N.V. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 1.23 | 382.3% | 21.9% | 1.54 | 452.0% | 18.4% |
| 55Δ | 1.18 | 422.8% | 21.7% | 1.64 | 436.0% | 15.9% |
| 60Δ | 1.14 | 463.4% | 21.5% | 1.75 | 420.0% | 13.3% |
| 65Δ | 1.09 | 503.9% | 21.3% | 1.85 | 404.0% | 10.8% |
| 70Δ | 1.05 | 544.5% | 21.2% | 1.96 | 388.0% | 8.3% |
| 75Δ | 1.00 | 585.0% | 21.0% | 2.12 | 379.2% | 6.3% |
| 80Δ | 2.31 | 375.3% | 4.7% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 1.23
- IV
- 382.3%
- B/E move
- 21.9%
- Pseudo strike
- 1.54
- IV
- 452.0%
- B/E move
- 18.4%
55Δ
- Pseudo strike
- 1.18
- IV
- 422.8%
- B/E move
- 21.7%
- Pseudo strike
- 1.64
- IV
- 436.0%
- B/E move
- 15.9%
60Δ
- Pseudo strike
- 1.14
- IV
- 463.4%
- B/E move
- 21.5%
- Pseudo strike
- 1.75
- IV
- 420.0%
- B/E move
- 13.3%
65Δ
- Pseudo strike
- 1.09
- IV
- 503.9%
- B/E move
- 21.3%
- Pseudo strike
- 1.85
- IV
- 404.0%
- B/E move
- 10.8%
70Δ
- Pseudo strike
- 1.05
- IV
- 544.5%
- B/E move
- 21.2%
- Pseudo strike
- 1.96
- IV
- 388.0%
- B/E move
- 8.3%
75Δ
- Pseudo strike
- 1.00
- IV
- 585.0%
- B/E move
- 21.0%
- Pseudo strike
- 2.12
- IV
- 379.2%
- B/E move
- 6.3%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.31
- IV
- 375.3%
- B/E move
- 4.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 166.84% | |
| 216.62% | |
| 253.46% | |
| 175.62% | |
| 139.96% | |
| 131.10% | |
| 109.97% | |
| 152.94% | |
| 162.09% | |
| 152.08% | |
| 125.68% | |
| 139.78% | |
| 171.13% | |
| 161.16% | |
| 173.96% | |
| 176.70% | |
| 208.04% | |
| 189.50% | |
| 234.22% | |
| 248.69% | |
| 305.19% | |
| 145.76% | |
| 161.03% | |
| 175.69% | |
| 216.54% | |
| 207.72% | |
| 150.25% | |
| 141.50% | |
| 216.06% | |
| 191.71% | |
| 200.68% | |
| 199.52% | |
| 248.07% | |
| 231.40% |
Biotechnology
IGC
Description unavailable
More →IMCR
Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is…
More →IMMX
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology and inflammation in the United…
More →IMNM
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapies for oncology and infectious diseases. The company is headquartered in Exton, Pennsylvania.
More →IMRX
Description unavailable
More →IMTX
Immatics NV, a clinical-stage biopharmaceutical company, focuses on the discovery and development of T-cell receptor (TCR) -based immunotherapies for the treatment of cancer in…
More →